No Picture

EQRx and Absci Announce Partnership to Discover and Develop Next-Generation Protein-Based Drugs

CAMBRIDGE, Mass., & VANCOUVER, Wash.–(BUSINESS WIRE)–EQRx, a new type of pharmaceutical company committed to developing and delivering important new medicines to patients at radically lower prices, and Absci Corporation (Nasdaq: ABSI), the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the therapeutic potential of… Click here to view original post… […]